{"abstract": "Wrapping up deals with Alere and St. Jude has troubled Abbott Laboratories; a cash infusion will come at a welcome time.", "web_url": "https://www.nytimes.com/2016/09/20/business/dealbook/abbotts-sale-of-eye-surgery-unit-should-ease-its-merger-woes.html", "snippet": "Wrapping up deals with Alere and St. Jude has troubled Abbott Laboratories; a cash infusion will come at a welcome time.", "lead_paragraph": "Abbott Laboratories may have eased the flow of its merger pipeline. The $62 billion health firm is selling its eye surgery unit to Johnson & Johnson for $4.3 billion. With two looming acquisitions worth over $30 billion \u2014 and the purchase of Alere, in particular, not going smoothly \u2014 it is a sensible way for Abbott to gain some breathing room.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Abbott\u2019s Sale of Eye Surgery Unit Should Ease Its Merger Woes", "kicker": "Breakingviews", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Abbott Laboratories", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 3, "major": "N"}, {"name": "organizations", "value": "St Jude Medical Inc", "rank": 4, "major": "N"}], "pub_date": "2016-09-19T17:30:32+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Robert Cyran", "person": [{"firstname": "Robert", "middlename": null, "lastname": "Cyran", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4e48b3cf-5a80-5ea1-8e97-5bb77139b81b", "word_count": 384, "uri": "nyt://article/4e48b3cf-5a80-5ea1-8e97-5bb77139b81b"}